TİP 2 DİYABETLİ HASTALARDA GLİSEMİK KONTROL DURUMU VE ETKİLEYEN ETMENLER: DEPRESYONUN ROLÜ

Yıl 2016, Cilt: 5 Sayı: 3, 70 - 79, 01.07.2016

Dilek Avcı Kevser Tarı Selçuk

Öz

Araştırmada ayaktan tedavi edilen tip 2 diyabetli hastalarda glisemik kontrol durumunun saptanması, depresyonun ve bazı sosyodemografik, klinik özelliklerin glisemik kontrol üzerine etkisinin belirlenmesi amaçlanmıştır. Kesitsel tipteki araştırma Ocak-Mart 2015 tarihleri arasında bir devlet hastanesi dahiliye polikliniğinde ayaktan tedavi edilen 279 hasta ile yürütülmüştür. Araştırmanın verileri Kişisel Bilgi Formu ve Beck Depresyon Ölçeği ile toplanmıştır. Veri analizinde tanımlayıcı istatistikler, ki kare, Fisher’in kesin testi ve lojistik regresyon analizi kullanılmıştır. Araştırma grubunun %27,2’sinde glisemik kontrolün sağlandığı belirlenmiştir. Lojistik regresyon modeline göre glisemik kontrolün 65 ve üzeri yaş grubunda 2,14 kat, normal Beden Kütle İndeksi’ne sahip olanlarda 1,45 kat, depresyon saptanmayanlarda 1,67 kat yüksek olduğu belirlenmiştir. Araştırmada yaklaşık her dört hastadan birinde glisemik kontrolün sağlandığı, BKİ ve depresyon düzeyinin glisemik kontrolü etkileyen değiştirilebilir birer risk faktörü olduğu belirlenmiştir.Bu doğrultuda koruyucu ruh sağlığı hizmetlerini içerecek şekilde diyabetlilerin nitelikli takibi sağlanmalıdır.

Anahtar Kelimeler

Tip 2 Diyabet, Glisemik Kontrol, Depresyon

GLYCEMIC CONTROL AND AFFECTING FACTORS IN PATIENTS WITH TYPE 2 DIABETES: THE ROLE OF DEPRESSION

Öz

In this study, it was aimed to determine glycemic control and the effects of depression and some sociodemographic and clinical factors on glycemic control in outpatients with Type 2 Diabetes. This cross-sectional study was conducted with 279 outpatients followed in the internal diseases department of a public hospital between January 2015 and March 2015. The data were collected using the Personal Information Form and Beck Depression Scale. Descriptive statistics, chi-square test, Fisher’s exact test, and logistics regression analysis were used to analyze the data. Glycemic control was achieved in 27.2% of the respondents. According to the logistic regression model, glycemic control was determined to be 2.14 times higher in the patients in the 65 and over age group, 1.45 times higher in those whose Body Mass Index was normal and 1.67 times higher in those having no depression than their counterparts. The results of the study revealed that glycemic control was achieved in one out of four patients, BMI and depression levels were determined to be modifiable risk factors affecting glycemic control. Therefore, quality monitoring of diabetic patients should include preventive mental health care.

Anahtar Kelimeler

Type 2 Diabetes, Glycemic Control, Depression

Kaynakça

• 1. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38:1-93.
• 2. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 2002; 25:1551-1556.
• 3. Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28:169-180.
• 4. Çıtıl R, Öztürk Y, Günay O. Kayseri il merkezinde bir sağlık ocağına başvuran diyabetik hastalarda metabolik kontrol durumu ve eşlik eden faktörler. Erciyes Tıp Dergisi 2010; 32:111-122.
• 5. Wee HL, Ho HK, Li SC. Public awareness of diabetes mellitus in Singapore Singapore Med J 2002; 43:128-134.
• 6. Buijsse B, Simmons RK, Griffin SJ, Schulze MB. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011; 33:46-62.
• 7. Tekeşin A, Doğan B, Yağız O, Polat H. Tip 2 diyabetli hastalarda serebrovasküler hastalık ile HBA1C arasındaki korelasyon. Istanbul Med J 2014; 15:40-42.
• 8. Guidelines for the prevention, management and care of diabetes mellitus. Available at: http://applications.emro.who.int/dsaf/dsa664.pdf. (Accessed January 12, 1016).
• 9. Tanrıverdi MH, Çelepkolu T, Aslanhan H. Diyabet ve birinci basamak sağlık hizmetleri. J Clin Exp Invest 2013; 4:562-567.
• 10. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes Mellitus. N Engl J Med 1993; 329:977-986.
• 11. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998; 352:854-865.
• 12. Tarı Selçuk K, Sözmen MK, Ünal B. Balçova’da 30 yaş ve üzeri diyabetlilerde tedavi alma ve kan glukoz düzeyinin kontrol altına alınma durumu. Turk J Public Health 2015; 13:40-52.
• 13. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011; 32:2143-2152.
• 14. Choe HM, Townsend KA, Blount G, Lo CH, Sadowski L, Standiford C. Treatment and control of blood pressure in patients with diabetes Mellitus. Am J Health-Syst Pharm 2007; 64:97-103.
• 15. Uysal Y, Akpınar E. Tip 2 diyabetli hastalarda hastalık algısı ve depresyon. Çukurova Tıp Dergisi 2013; 38:31-40.
• 16. Ghazanfari Z, Niknami S, Ghofranipour F, Larijani B, Agha-Alinejad H, Montazeri A. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids Health Dis 2010; 9:1-5.
• 17. Güçlü YA, Yıldız ED, Ünsal F, Öngel K. Diyabetli hastalarda uygulanan hızlı depresif belirti envanteri özbildirim formu ve beck depresyon ölçeklerinin değerlendirilmesi. Tepecik Eğit Hast Derg 2013; 23:113- 119.
• 18. Van den Akker M, Schuurman A, Metsemakers J, Buntinx F. Is depression related to subsequent diabetes mellitus?. Acta Psychiatr Scand 2004; 110:178-183.
• 19. De Long DE, Stepita RA, Taylor VH, Holloway DC. Major Depressive Disorder and Diabetes: Does Serotonin Bridge the Gap? Curr Diabetes Rev 2015; 11:71-78.
• 20. Bahar A, Sertbaş G, Sönmez A. Diabetes mellituslu hastaların depresyon ve anksiyete düzeylerinin belirlenmesi. Anadolu Psikiyatri Dergisi 2006; 7:18-26.
• 21. Shah BM, Mezzio DJ, Ho J, Ip EJ. Association of ABC (HbA1c, blood pressure, LDL-cholesterol) goal attainment with depression and health-related quality of life among adults with type 2 diabetes. J Diabetes Complications 2015; 29:794-800.
• 22. Singh H, Raju MSVK, Dubey V, Kurrey R, Bansal S, Malik M. A study of sociodemographic clinical and glycemic control factors associated with co-morbid depression in type 2 diabetes Mellitus. Ind Psychiatry J 2014; 23:134-142.
• 23. Eren İ, Erdi Ö, Özcankaya R. Tip II diyabetik hastalarda kan şekeri kontrolü ile psikiyatrik bozuklukların ilişkisi. Türk Psikiyatri Dergisi 2003; 14:184-191.
• 24. Use of Glycated Haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Available at: http://www.who.int/diabetes/publications/reporthba1c_2011.pdf. (Accessed January 13, 2016).
• 25. Obesity preventing and managing the global epidemic. Available at: http://www.who.int/nutrition/publications/obesity/WHO_T RS_894/en/ (Accessed January 15, 2016).
• 26. Hisli N. Beck Depresyon Envanteri’nin üniversite öğrencileri için geçerliliği, güvenilirliği. Psikoloji Dergisi 1989; 7:3-13.
• 27. Ersoy C, Tuncel E, Özdemir B, Ertürk E, İmamoğlu Ş. İnsülin kullanan tip 2 diabetes mellituslu hastalarda diyabet eğitimi ve metabolik kontrol. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2006; 32:43-47.
• 28. Chen R, Ji L, Zou D. Glycemic control rate of T2DM outpatients in China: a multi-center survey. Med Sci Monit 2015; 19:1440-1446.
• 29. Wong ND, Patao C, Malik S, Iloeje U. Preventable coronary heart disease events from control of cardiyovasculer risk factors in US adults with diabetes (projection from utulizing the UKPDS risk engine). Am J Cardiol 2014; 113:1356-1361.
• 30. Sazlina SG, Mastura I, Ahmad Z, Cheong AT, Adam BM, Jamaiyah H et al. Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: data from the Adult diabetes control and management. Geriatr Gerontol Int 2014;4:7-130.
• 31. Oguz A, Gedik O, Hatemi H, Yılmaz MT, İmamoğlu Ş, Kamel N et al. Glysemic control of Turkısh adult diabetic patients. Turk J Endokrinol Metab 2008; 12:50-54.
• 32. Önsüz MF, Topuzoğlu A. İstanbul ilinde çeşitli sağlık kuruluşlarında ayaktan tip 2 diyabetli hastalarda glisemik kontrolün ve etkileyen faktörlerin değerlendirilmesi. Nobel Med 2010; 6:45-55.
• 33. Hermann G, Herbst A, Schutt M. Association of physical activity with glycemic control and cardiovascular risk profile in 65 666 people with type 2 diabetes from Germany and Austria. Diabet Med 2014; 31:905-912.
• 34. Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE. Factors ınfluencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care 2007; 30:459-466.
• 35. Bouwman V, Adriaanse MC, Van’t Riet E, Snoek FJ, Dekker JM, Nijpels G et al. Depression, anxiety and glucose metabolism in the general Dutch population: the New Hoorn study. PLoS One 2010; 5:1-7.
• 36. Lin EH, Korff MV, Alonso J, Angermeyer MC, Anthony J, Bromet E, Bruffaerts R et al. Mental disorders among persons with diabetes-results from the World Mental Health Surveys. J Psychosom Res 2008; 65:571-580.
• 37. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K et al. Type 2 diabetes mellitus as a risk factor for onset of depression: a systematic review and metaanalysis. Diabetologia 2010; 12:2480-2486.
• 38. Pan A, Lucas M, Sun Q, Van Dam RM, Franco OH, Willett WC et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011; 68:42-50.
• 39. Hamer M, Stamatakis E, Kivimaki M, Pascal Kengne A, Batty GD. Psychological distress, glycated hemoglobin, and mortality in adults with and without diabetes. Psychosom Med 2010; 72:882-886.
• 40. Pouwer F, Beekman ATF, Lubach C, Snoek FJ. Nurses’ recognition and registration of depression, anxiety and diabetes-spesific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns 2006; 60:235-240.
• 41. Rubin R, Ciechanowski P, Egede L, Lin E, Lustman P. Recognizing and treating depression in patients with diabetes. Curr Diab Rep 2004; 4:119-125.
• 42. Wagner JA, Abbott GL, Heapy A, Yong L. Depressive symptoms and diabetes control in African Americans. J Immigr Minor Health 2009;11:66-70.
• 43. Rustad JK, Musselman DL, Nemeroff CB. The relationship of depression and diabetes: pathophysiological ans treatment implications. Psychoneuroendocrinology 2011; 36:1276-1286.
• 44. Richardson LK, Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp Psychiatry 2008; 30:509-514.
• 45. Bi Y, Zhu D, Cheng J, Zhu Y, Xu N, Cui S et al. The status of glycemic control:a cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther 2010; 32:973-983.
• 46. Khattaba M, Khaderb YS, Al-Khawaldehd A, Ajlounid K. Factors associated with poor glycemic control among patients with type 2 diabetes. Journal of Diabetes and Its Complications 2010; 24:84-89.
• 47. Kamath A, Shivaprakash G, Adhikari P. Body mass index and waist circumference in type 2 diabetes mellitus patients attending a diabetes clinic. Int J Biol Med Res 2011; 2:636- 638.